DAFTAR PUSTAKA

1. Kementerian Kesehatan Republik Indonesia, 2020, Panduan Pencegahan dan

Pengendalian Corona Virus Disease (Covid19), Available at :
https://www.researchgate.net/pu blication/340380088_Coronaviru
s_Disease_2019_Tinjauan_Liter atur_Terkini
2. Wang Z, Qiang W, Ke H. A Handbook of 2019-nCoV Pneumonia Control and
Prevention. Hubei Sci Technol Press. 2020;1–108.
3. Wang Z, Qiang W, Ke H. A Handbook of 2019-nCoV Pneumonia Control and
Prevention. Hubei Sci Technol Press. 2020;1–108.
4. Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M,
Herikurniawan H, et al. Coronavirus Disease 2019: Tinjauan Literatur
Terkini. J Penyakit Dalam Indones. 2020;7(1):45
5. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2
Associated with the COVID-19 Outbreak. Curr Biol [Internet].
2020;30(7):1346- 1351.e2.
6. De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS:
Recent insights into emerging coronaviruses. Nat Rev Microbiol.
2016;14(8):523–34.
7. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and
immune responses. J Med Virol. 2020;92(4):424– 32.
8. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and
diagnosis of COVID-19. J Pharm Anal [Internet]. 2020;10(2):102–8.
9. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of
global health concern. Lancet. 2020;395(10223):470–3.
10. Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality
from 2019- nCoV: host-directed therapies should be an option. Lancet
[Internet]. 2020;395(10224):e35–6.
11. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the
Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a
Report of 72314 Cases From the Chinese Center for Disease Control and
Prevention. JAMA. 2020; published online February 24. DOI:
10.1001/jama.2020.2648.
12. World Health Organization. Situation Report – 10 [Internet]. 2020 [updated
2020 January 30; cited 2020 March 15]. Available from:
https://www.who.int/docs/default-source/ coronaviruse/situation-
reports/20200130-sitrep-10-ncov. pdf?sfvrsn=d0b2e480_2.
13. World Health Organization. Situation Report – 42 [Internet]. 2020 [updated
2020 March 02; cited 2020 March 15]. Available from:
 https://www.who.int/docs/default-source/ coronaviruse/situation-
reports/20200302-sitrep-42-covid-19. pdf?sfvrsn=224c1add_2.
14. Kementerian Kesehatan Republik Indonesia. Info Infeksi Emerging
Kementerian Kesehatan RI [Internet]. 2020 [updated 2020 March 30; cited
2020 March 31]. Available from: https:// infeksiemerging.kemkes.go.id/.
15. World Health Organization. Novel Coronavirus (2019-nCoV) Situation
Report - 54 [Internet]. WHO; 2020 [updated 2020 March 15; cited 2020
March 30]. Available from: https://www.who.int/ docs/default-
source/coronaviruse/situation-reports/20200314- sitrep-54-covid-19.pdf?
sfvrsn=dcd46351_2.
16. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation
Report – 70 [Internet]. WHO; 2020 [updated 2020 March 30; cited 2020
March 31]. Available from: https://www.who.int/ docs/default-
source/coronaviruse/situation-reports/20200330- sitrep-70-covid-19.pdf?
sfvrsn=7e0fe3f8_2
17. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and
diagnosis of COVID-19. J Pharm Anal. 2020; published online March 5. DOI:
10.1016/j.jpha.2020.03.001
18. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS:
recent insights into emerging coronaviruses. Nat Rev Microbiol.
2016;14(8):523-34.
19. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P.
Characterization of severe acute respiratory syndromeassociated coronavirus
(SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S
A. 2004;101(12):4240-5.